HEADER TRANSFERASE 15-FEB-06 2G2F TITLE A SRC-LIKE INACTIVE CONFORMATION IN THE ABL TYROSINE KINASE DOMAIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: ABL KINASE; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: ABL KINASE DOMAIN; COMPND 5 SYNONYM: P150, C- ABL, ABELSON MURINE LEUKEMIA VIRAL ONCOGENE HOMOLOG COMPND 6 1; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: ATP-PEPTIDE CONJUGATE; COMPND 11 CHAIN: C; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ABL1, ABL, JTK7; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES; SOURCE 10 OTHER_DETAILS: SOLID PHASE PEPTIDE SYNTHESIS KEYWDS PROTEIN KINASE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR N.M.LEVINSON,O.KUCHMENT REVDAT 6 13-NOV-24 2G2F 1 REMARK REVDAT 5 30-AUG-23 2G2F 1 REMARK REVDAT 4 20-OCT-21 2G2F 1 REMARK SEQADV LINK REVDAT 3 07-MAR-12 2G2F 1 HET HETATM HETNAM VERSN REVDAT 2 24-FEB-09 2G2F 1 VERSN REVDAT 1 23-MAY-06 2G2F 0 JRNL AUTH N.M.LEVINSON,O.KUCHMENT,K.SHEN,M.A.YOUNG,M.KOLDOBSKIY, JRNL AUTH 2 M.KARPLUS,P.A.COLE,J.KURIYAN JRNL TITL A SRC-LIKE INACTIVE CONFORMATION IN THE ABL TYROSINE KINASE JRNL TITL 2 DOMAIN. JRNL REF PLOS BIOL. V. 4 753 2006 JRNL REFN ISSN 1544-9173 JRNL PMID 16640460 JRNL DOI 10.1371/JOURNAL.PBIO.0040144 REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 22582 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.232 REMARK 3 FREE R VALUE : 0.286 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1115 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4435 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 66 REMARK 3 SOLVENT ATOMS : 85 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 52.80 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.370 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : ISOTROPIC REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2G2F COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 04-APR-06. REMARK 100 THE DEPOSITION ID IS D_1000036603. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 8.2.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.115879 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22582 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.11000 REMARK 200 FOR THE DATA SET : 10.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.80 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.2 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.49400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.050 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 1M52 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.28 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.95 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M BIS-TRIS PH 5.5, 25% PEG 3350, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 52.83450 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 66.66100 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 52.83450 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 66.66100 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1910 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 14040 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -11.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 226 REMARK 465 HIS A 227 REMARK 465 MET A 228 REMARK 465 SER A 229 REMARK 465 PRO A 230 REMARK 465 ASN A 231 REMARK 465 GLU A 507 REMARK 465 LYS A 508 REMARK 465 GLU A 509 REMARK 465 LEU A 510 REMARK 465 GLY A 511 REMARK 465 LYS A 512 REMARK 465 GLY B 226 REMARK 465 HIS B 227 REMARK 465 MET B 228 REMARK 465 SER B 229 REMARK 465 PRO B 230 REMARK 465 ASN B 231 REMARK 465 TYR B 232 REMARK 465 ASP B 233 REMARK 465 GLY B 249 REMARK 465 GLY B 250 REMARK 465 GLY B 251 REMARK 465 GLN B 252 REMARK 465 TYR B 253 REMARK 465 SER B 503 REMARK 465 ASP B 504 REMARK 465 GLU B 505 REMARK 465 VAL B 506 REMARK 465 GLU B 507 REMARK 465 LYS B 508 REMARK 465 GLU B 509 REMARK 465 LEU B 510 REMARK 465 GLY B 511 REMARK 465 LYS B 512 REMARK 465 ALA C 112 REMARK 465 LYS C 113 REMARK 465 LYS C 114 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP A 504 CG OD1 OD2 REMARK 470 GLU A 505 CG CD OE1 OE2 REMARK 470 VAL A 506 CG1 CG2 REMARK 470 GLU B 255 CG CD OE1 OE2 REMARK 470 GLU C 104 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 233 131.60 -172.75 REMARK 500 LYS A 245 -67.95 -100.56 REMARK 500 GLN A 252 19.07 -65.61 REMARK 500 TYR A 253 9.49 -151.64 REMARK 500 LYS A 262 -63.48 -29.42 REMARK 500 LEU A 273 117.59 -164.18 REMARK 500 LYS A 274 -148.53 -97.26 REMARK 500 GLU A 275 34.25 -78.94 REMARK 500 ASP A 276 -132.02 -57.71 REMARK 500 VAL A 280 -61.84 -26.86 REMARK 500 LYS A 357 16.91 -64.82 REMARK 500 LEU A 387 113.11 -170.82 REMARK 500 TYR A 440 61.43 35.31 REMARK 500 SER A 481 2.62 -67.40 REMARK 500 ASP A 504 -74.91 -70.42 REMARK 500 GLU A 505 -8.53 -53.36 REMARK 500 GLU B 236 135.00 -35.85 REMARK 500 MET B 237 -155.46 -130.00 REMARK 500 ARG B 239 22.07 -77.15 REMARK 500 LYS B 245 -33.63 -144.05 REMARK 500 TYR B 264 -9.98 70.38 REMARK 500 SER B 265 66.83 36.88 REMARK 500 GLU B 316 157.45 -46.12 REMARK 500 ASP B 363 64.12 -156.40 REMARK 500 PHE B 382 -74.15 -2.81 REMARK 500 THR B 389 -53.85 -131.33 REMARK 500 PRO B 396 151.15 -47.47 REMARK 500 ALA B 397 -95.69 3.62 REMARK 500 ALA B 399 119.30 -27.19 REMARK 500 PRO B 402 104.92 -59.22 REMARK 500 ASP B 455 28.70 80.95 REMARK 500 SER B 501 -137.10 -93.33 REMARK 500 ALA C 105 100.69 113.37 REMARK 500 PRO C 110 155.58 -41.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE AGS B 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 112 C 201 DBREF 2G2F A 229 512 UNP P00519 ABL1_HUMAN 229 512 DBREF 2G2F B 229 512 UNP P00519 ABL1_HUMAN 229 512 DBREF 2G2F C 104 114 PDB 2G2F 2G2F 104 114 SEQADV 2G2F GLY A 226 UNP P00519 CLONING ARTIFACT SEQADV 2G2F HIS A 227 UNP P00519 CLONING ARTIFACT SEQADV 2G2F MET A 228 UNP P00519 CLONING ARTIFACT SEQADV 2G2F PRO A 396 UNP P00519 HIS 396 ENGINEERED MUTATION SEQADV 2G2F GLY B 226 UNP P00519 CLONING ARTIFACT SEQADV 2G2F HIS B 227 UNP P00519 CLONING ARTIFACT SEQADV 2G2F MET B 228 UNP P00519 CLONING ARTIFACT SEQADV 2G2F PRO B 396 UNP P00519 HIS 396 ENGINEERED MUTATION SEQRES 1 A 287 GLY HIS MET SER PRO ASN TYR ASP LYS TRP GLU MET GLU SEQRES 2 A 287 ARG THR ASP ILE THR MET LYS HIS LYS LEU GLY GLY GLY SEQRES 3 A 287 GLN TYR GLY GLU VAL TYR GLU GLY VAL TRP LYS LYS TYR SEQRES 4 A 287 SER LEU THR VAL ALA VAL LYS THR LEU LYS GLU ASP THR SEQRES 5 A 287 MET GLU VAL GLU GLU PHE LEU LYS GLU ALA ALA VAL MET SEQRES 6 A 287 LYS GLU ILE LYS HIS PRO ASN LEU VAL GLN LEU LEU GLY SEQRES 7 A 287 VAL CYS THR ARG GLU PRO PRO PHE TYR ILE ILE THR GLU SEQRES 8 A 287 PHE MET THR TYR GLY ASN LEU LEU ASP TYR LEU ARG GLU SEQRES 9 A 287 CYS ASN ARG GLN GLU VAL ASN ALA VAL VAL LEU LEU TYR SEQRES 10 A 287 MET ALA THR GLN ILE SER SER ALA MET GLU TYR LEU GLU SEQRES 11 A 287 LYS LYS ASN PHE ILE HIS ARG ASP LEU ALA ALA ARG ASN SEQRES 12 A 287 CYS LEU VAL GLY GLU ASN HIS LEU VAL LYS VAL ALA ASP SEQRES 13 A 287 PHE GLY LEU SER ARG LEU MET THR GLY ASP THR TYR THR SEQRES 14 A 287 ALA PRO ALA GLY ALA LYS PHE PRO ILE LYS TRP THR ALA SEQRES 15 A 287 PRO GLU SER LEU ALA TYR ASN LYS PHE SER ILE LYS SER SEQRES 16 A 287 ASP VAL TRP ALA PHE GLY VAL LEU LEU TRP GLU ILE ALA SEQRES 17 A 287 THR TYR GLY MET SER PRO TYR PRO GLY ILE ASP LEU SER SEQRES 18 A 287 GLN VAL TYR GLU LEU LEU GLU LYS ASP TYR ARG MET GLU SEQRES 19 A 287 ARG PRO GLU GLY CYS PRO GLU LYS VAL TYR GLU LEU MET SEQRES 20 A 287 ARG ALA CYS TRP GLN TRP ASN PRO SER ASP ARG PRO SER SEQRES 21 A 287 PHE ALA GLU ILE HIS GLN ALA PHE GLU THR MET PHE GLN SEQRES 22 A 287 GLU SER SER ILE SER ASP GLU VAL GLU LYS GLU LEU GLY SEQRES 23 A 287 LYS SEQRES 1 B 287 GLY HIS MET SER PRO ASN TYR ASP LYS TRP GLU MET GLU SEQRES 2 B 287 ARG THR ASP ILE THR MET LYS HIS LYS LEU GLY GLY GLY SEQRES 3 B 287 GLN TYR GLY GLU VAL TYR GLU GLY VAL TRP LYS LYS TYR SEQRES 4 B 287 SER LEU THR VAL ALA VAL LYS THR LEU LYS GLU ASP THR SEQRES 5 B 287 MET GLU VAL GLU GLU PHE LEU LYS GLU ALA ALA VAL MET SEQRES 6 B 287 LYS GLU ILE LYS HIS PRO ASN LEU VAL GLN LEU LEU GLY SEQRES 7 B 287 VAL CYS THR ARG GLU PRO PRO PHE TYR ILE ILE THR GLU SEQRES 8 B 287 PHE MET THR TYR GLY ASN LEU LEU ASP TYR LEU ARG GLU SEQRES 9 B 287 CYS ASN ARG GLN GLU VAL ASN ALA VAL VAL LEU LEU TYR SEQRES 10 B 287 MET ALA THR GLN ILE SER SER ALA MET GLU TYR LEU GLU SEQRES 11 B 287 LYS LYS ASN PHE ILE HIS ARG ASP LEU ALA ALA ARG ASN SEQRES 12 B 287 CYS LEU VAL GLY GLU ASN HIS LEU VAL LYS VAL ALA ASP SEQRES 13 B 287 PHE GLY LEU SER ARG LEU MET THR GLY ASP THR TYR THR SEQRES 14 B 287 ALA PRO ALA GLY ALA LYS PHE PRO ILE LYS TRP THR ALA SEQRES 15 B 287 PRO GLU SER LEU ALA TYR ASN LYS PHE SER ILE LYS SER SEQRES 16 B 287 ASP VAL TRP ALA PHE GLY VAL LEU LEU TRP GLU ILE ALA SEQRES 17 B 287 THR TYR GLY MET SER PRO TYR PRO GLY ILE ASP LEU SER SEQRES 18 B 287 GLN VAL TYR GLU LEU LEU GLU LYS ASP TYR ARG MET GLU SEQRES 19 B 287 ARG PRO GLU GLY CYS PRO GLU LYS VAL TYR GLU LEU MET SEQRES 20 B 287 ARG ALA CYS TRP GLN TRP ASN PRO SER ASP ARG PRO SER SEQRES 21 B 287 PHE ALA GLU ILE HIS GLN ALA PHE GLU THR MET PHE GLN SEQRES 22 B 287 GLU SER SER ILE SER ASP GLU VAL GLU LYS GLU LEU GLY SEQRES 23 B 287 LYS SEQRES 1 C 11 GLU ALA ILE PHE ALA ALA PRO PHE ALA LYS LYS HET AGS B 601 31 HET 112 C 201 35 HETNAM AGS PHOSPHOTHIOPHOSPHORIC ACID-ADENYLATE ESTER HETNAM 112 THIOPHOSPHORIC ACID O-((ADENOSYL-PHOSPHO)PHOSPHO)-S- HETNAM 2 112 ACETAMIDYL-DIESTER HETSYN AGS ATP-GAMMA-S; ADENOSINE 5'-(3-THIOTRIPHOSPHATE); HETSYN 2 AGS ADENOSINE 5'-(GAMMA-THIOTRIPHOSPHATE); ADENOSINE-5'- HETSYN 3 AGS DIPHOSPHATE MONOTHIOPHOSPHATE FORMUL 4 AGS C10 H16 N5 O12 P3 S FORMUL 5 112 C12 H19 N6 O13 P3 S FORMUL 6 HOH *85(H2 O) HELIX 1 1 GLU A 238 THR A 240 5 3 HELIX 2 2 LYS A 263 SER A 265 5 3 HELIX 3 3 GLU A 279 LYS A 291 1 13 HELIX 4 4 ASN A 322 CYS A 330 1 9 HELIX 5 5 ASN A 336 LYS A 357 1 22 HELIX 6 6 ALA A 365 ARG A 367 5 3 HELIX 7 7 GLU A 373 HIS A 375 5 3 HELIX 8 8 LYS A 404 THR A 406 5 3 HELIX 9 9 ALA A 407 ASN A 414 1 8 HELIX 10 10 SER A 417 THR A 434 1 18 HELIX 11 11 ASP A 444 SER A 446 5 3 HELIX 12 12 GLN A 447 LYS A 454 1 8 HELIX 13 13 PRO A 465 TRP A 476 1 12 HELIX 14 14 ASN A 479 ARG A 483 5 5 HELIX 15 15 SER A 485 VAL A 506 1 22 HELIX 16 16 LYS B 263 SER B 265 5 3 HELIX 17 17 GLU B 279 LYS B 291 1 13 HELIX 18 18 ASN B 322 CYS B 330 1 9 HELIX 19 19 ASN B 336 ASN B 358 1 23 HELIX 20 20 ALA B 365 ARG B 367 5 3 HELIX 21 21 PRO B 402 THR B 406 5 5 HELIX 22 22 ALA B 407 ASN B 414 1 8 HELIX 23 23 ILE B 418 ALA B 433 1 16 HELIX 24 24 ASP B 444 SER B 446 5 3 HELIX 25 25 GLN B 447 LYS B 454 1 8 HELIX 26 26 PRO B 465 TRP B 476 1 12 HELIX 27 27 ASN B 479 ARG B 483 5 5 HELIX 28 28 SER B 485 GLU B 499 1 15 SHEET 1 A 5 ILE A 242 GLY A 249 0 SHEET 2 A 5 VAL A 256 TRP A 261 -1 O GLU A 258 N HIS A 246 SHEET 3 A 5 LEU A 266 LEU A 273 -1 O VAL A 270 N TYR A 257 SHEET 4 A 5 PHE A 311 GLU A 316 -1 O THR A 315 N ALA A 269 SHEET 5 A 5 LEU A 301 CYS A 305 -1 N LEU A 302 O ILE A 314 SHEET 1 B 2 PHE A 359 HIS A 361 0 SHEET 2 B 2 LEU A 384 ARG A 386 -1 O SER A 385 N ILE A 360 SHEET 1 C 2 CYS A 369 GLY A 372 0 SHEET 2 C 2 LEU A 376 VAL A 379 -1 O LEU A 376 N GLY A 372 SHEET 1 D 2 TYR A 393 THR A 394 0 SHEET 2 D 2 LYS A 415 PHE A 416 -1 O PHE A 416 N TYR A 393 SHEET 1 E 2 PHE A 401 PRO A 402 0 SHEET 2 E 2 PHE C 107 ALA C 108 -1 O ALA C 108 N PHE A 401 SHEET 1 F 5 ILE B 242 LYS B 247 0 SHEET 2 F 5 GLU B 255 TRP B 261 -1 O GLU B 258 N HIS B 246 SHEET 3 F 5 LEU B 266 LEU B 273 -1 O VAL B 270 N TYR B 257 SHEET 4 F 5 PHE B 311 GLU B 316 -1 O THR B 315 N ALA B 269 SHEET 5 F 5 LEU B 301 CYS B 305 -1 N GLY B 303 O ILE B 314 SHEET 1 G 2 PHE B 359 HIS B 361 0 SHEET 2 G 2 LEU B 384 ARG B 386 -1 O SER B 385 N ILE B 360 SHEET 1 H 2 CYS B 369 VAL B 371 0 SHEET 2 H 2 VAL B 377 VAL B 379 -1 O LYS B 378 N LEU B 370 SHEET 1 I 2 THR B 392 THR B 394 0 SHEET 2 I 2 LYS B 415 SER B 417 -1 O PHE B 416 N TYR B 393 LINK CZ PHE C 107 NS 112 C 201 1555 1555 1.47 CISPEP 1 PRO A 309 PRO A 310 0 -0.09 CISPEP 2 PRO B 309 PRO B 310 0 -0.17 SITE 1 AC1 10 LEU B 248 VAL B 256 ALA B 269 THR B 315 SITE 2 AC1 10 GLU B 316 PHE B 317 MET B 318 GLY B 321 SITE 3 AC1 10 ASN B 322 ARG B 367 SITE 1 AC2 15 LEU A 248 GLY A 250 GLY A 251 GLN A 252 SITE 2 AC2 15 VAL A 256 ALA A 269 LYS A 271 THR A 315 SITE 3 AC2 15 GLU A 316 PHE A 317 MET A 318 ASN A 322 SITE 4 AC2 15 ASP A 363 HOH A 635 PHE C 107 CRYST1 105.669 133.322 56.576 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009464 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007501 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017675 0.00000